The Ethiopian Pharmaceuticals Supply Agency has been working to ensure an efficient supply chain that provides equitable access and affordable Anti-cancer medicines for Ethiopians. Cancer is a major public health problem in many low-income countries (LICs), including Ethiopia. A survey indicates that 64,000 new cases of cancer occur annually. Studies supported that In Ethiopia, cancer accounts for about 5.8% of total national mortality. Currently, even though there is good progress many gaps have been observed which need to be addressed to ensure absolute efficiency for example high expiry and wastage, frequent stock out, facility, data visibility issues, product delivery delay, intermittent reports, facility complaints and inadequate communication.
Join Capital Berhanu as he shares his experiences and recommendations to ensure the reliability of these life saving supply chains.